Francesca Protopapa

Turin, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Complex I Modulator BI4500 Reduces MASH by Limiting Oxidative Stress and Reprogramming Lipid Metabolism via AMPK in MCD Rats.

Complex I Modulator BI4500 Reduces MASH by Limiting Oxidative Stress and Reprogramming Lipid Metabolism via AMPK in MCD Rats.

Journal: Antioxidants (Basel, Switzerland)

Published: November 21, 2025

Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis.

Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis.

Journal: Frontiers in immunology

Published: November 21, 2023

The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis.

The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis.

Journal: Molecular metabolism

Published: October 27, 2023

SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness.

SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness.

Journal: Biology

Published: March 07, 2023

Hepatic Myofibroblasts: A Heterogeneous and Redox-Modulated Cell Population in Liver Fibrogenesis.

Hepatic Myofibroblasts: A Heterogeneous and Redox-Modulated Cell Population in Liver Fibrogenesis.

Journal: Antioxidants (Basel, Switzerland)

Published: May 03, 2022

SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease.

SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease.

Journal: Frontiers in immunology

Published: April 01, 2022

Hypoxia, Hypoxia-Inducible Factors and Liver Fibrosis.

Hypoxia, Hypoxia-Inducible Factors and Liver Fibrosis.

Journal: Cells

Published: June 14, 2021

Liver fibrogenesis: un update on established and emerging basic concepts.

Liver fibrogenesis: un update on established and emerging basic concepts.

Journal: Archives of biochemistry and biophysics

Published: February 27, 2020

Showing 1-8 of 8

Last Updated: 09/26/2026